Clinical Trial Update: Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

View source ↗

Summary

A completed clinical trial evaluated the safety of NovoPen 3 and FlexPen devices in routine clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• FlexPen
• NovoPen 3

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED